0 projects

H20-HEALTH-Health, demographic change and wellbeing

Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders

Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders

Awarded: NOK 17.9 mill.

Project Period: 2021-2025

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis

The objective of the current proposal is to advance the orphan drug OligoG CF-5/20 (OligoG) through a pivotal phase IIb clinical trial, to enable a new and improved therapeutic approach for the orphan disease cystic fibrosis by 2024. The study drug is an alginate oligosaccharide derived from sea...

Awarded: NOK 53.4 mill.

Project Period: 2018-2022

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Soraprazan - a new regenerative therapy for Stargardt's disease

Soraprazan – a new regenerative therapy for Stargardt’s disease Abnormal accumulation of lipofuscin in the RPE cells is a hallmark in Stargardt's disease. As lipofuscin cannot be removed from the RPE cells in the eyes neither spontaneously nor with existing therapies, the accumulation of lipofus...

Awarded: NOK 14.6 mill.

Project Period: 2017-2021

Location: Oslo

HEALTH-1.01 Health

A new therapeutic antibody with a personalised medicine approach in cardiovascular disease

-

Awarded: NOK 3.2 mill.

Project Period: 2013-2016

Location: Oslo

HEALTH-1.01 Health

New approach to treatment of the blinding disease Retinopathy of Prematurity (ROP)

-

Awarded: NOK 6.4 mill.

Project Period: 2012-2017

Location: Oslo